JP2007536911A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007536911A5 JP2007536911A5 JP2006547589A JP2006547589A JP2007536911A5 JP 2007536911 A5 JP2007536911 A5 JP 2007536911A5 JP 2006547589 A JP2006547589 A JP 2006547589A JP 2006547589 A JP2006547589 A JP 2006547589A JP 2007536911 A5 JP2007536911 A5 JP 2007536911A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- sequence
- acid sequence
- composition
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 14
- 239000000427 antigen Substances 0.000 claims 13
- 102000036639 antigens Human genes 0.000 claims 13
- 108091007433 antigens Proteins 0.000 claims 13
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims 10
- 229920001184 polypeptide Polymers 0.000 claims 9
- 102000004196 processed proteins & peptides Human genes 0.000 claims 9
- 102000053602 DNA Human genes 0.000 claims 8
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 6
- 230000003053 immunization Effects 0.000 claims 5
- 108020004414 DNA Proteins 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 108020004511 Recombinant DNA Proteins 0.000 claims 4
- 230000001363 autoimmune Effects 0.000 claims 4
- 239000012678 infectious agent Substances 0.000 claims 4
- 230000026683 transduction Effects 0.000 claims 4
- 238000010361 transduction Methods 0.000 claims 4
- 101000579484 Homo sapiens Period circadian protein homolog 1 Proteins 0.000 claims 2
- 102100028293 Period circadian protein homolog 1 Human genes 0.000 claims 2
- 210000004443 dendritic cell Anatomy 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 238000007920 subcutaneous administration Methods 0.000 claims 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53372803P | 2003-12-31 | 2003-12-31 | |
| PCT/US2004/044023 WO2005066203A2 (en) | 2003-12-31 | 2004-12-30 | Targeted immunogens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007536911A JP2007536911A (ja) | 2007-12-20 |
| JP2007536911A5 true JP2007536911A5 (enExample) | 2008-06-26 |
Family
ID=34748948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006547589A Abandoned JP2007536911A (ja) | 2003-12-31 | 2004-12-30 | 標的抗原 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20060002946A1 (enExample) |
| EP (1) | EP1699492A2 (enExample) |
| JP (1) | JP2007536911A (enExample) |
| KR (1) | KR20060129353A (enExample) |
| CN (1) | CN1921889A (enExample) |
| AU (1) | AU2004312548A1 (enExample) |
| BR (1) | BRPI0418273A (enExample) |
| CA (1) | CA2552251A1 (enExample) |
| IL (1) | IL176603A0 (enExample) |
| MX (1) | MXPA06007574A (enExample) |
| WO (1) | WO2005066203A2 (enExample) |
| ZA (1) | ZA200605304B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0103110D0 (en) * | 2000-08-25 | 2001-03-28 | Aventis Pharma Inc | A membrane penetrating peptide encoded by a nuclear localization sequence from human period 1 |
| WO2012123755A1 (en) | 2011-03-17 | 2012-09-20 | The University Of Birmingham | Re-directed immunotherapy |
| KR20170116039A (ko) * | 2015-02-18 | 2017-10-18 | 에프. 호프만-라 로슈 아게 | 표적 세포에 대항하여 t 세포 세포독성을 특이적으로 유도하기 위한 면역컨주게이트 |
| CA2984629C (en) | 2015-05-07 | 2024-06-18 | University Of South Florida | Modified ube3a gene for a gene therapy approach for angelman syndrome |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE391791T1 (de) * | 2000-08-25 | 2008-04-15 | Aventis Pharma Inc | Membran penetrierende peptide und deren anwendungen |
| CA2477429A1 (en) * | 2002-01-29 | 2003-08-07 | Robert A. Uger | Targeted immunogens |
-
2004
- 2004-12-30 AU AU2004312548A patent/AU2004312548A1/en not_active Abandoned
- 2004-12-30 MX MXPA06007574A patent/MXPA06007574A/es unknown
- 2004-12-30 BR BRPI0418273-1A patent/BRPI0418273A/pt not_active IP Right Cessation
- 2004-12-30 US US11/026,403 patent/US20060002946A1/en not_active Abandoned
- 2004-12-30 WO PCT/US2004/044023 patent/WO2005066203A2/en not_active Ceased
- 2004-12-30 CA CA002552251A patent/CA2552251A1/en not_active Abandoned
- 2004-12-30 CN CNA2004800421537A patent/CN1921889A/zh active Pending
- 2004-12-30 JP JP2006547589A patent/JP2007536911A/ja not_active Abandoned
- 2004-12-30 KR KR1020067015438A patent/KR20060129353A/ko not_active Withdrawn
- 2004-12-30 EP EP04816007A patent/EP1699492A2/en not_active Withdrawn
-
2006
- 2006-06-27 ZA ZA200605304A patent/ZA200605304B/en unknown
- 2006-06-28 IL IL176603A patent/IL176603A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003070760A3 (en) | Anti-amyloid beta antibodies and their use | |
| WO2007106476A3 (en) | Compositions and methods for enhancing the immunogenicity of antigens | |
| JP2009511000A5 (enExample) | ||
| WO2007091030A3 (en) | Peptide sequences and compositions | |
| WO2007028574A3 (en) | Tumor-associated peptides binding promiscuously to human leukocyte antigen (hla) class ii molecules | |
| JP2012500001A5 (enExample) | ||
| WO2005086794A3 (en) | Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor | |
| EP2562183A8 (en) | Novel immunogenic epitopes for immunotherapy | |
| JP2013538555A5 (enExample) | ||
| WO2009018126A3 (en) | Collagen-related peptides and uses thereof | |
| WO2003083124A3 (fr) | Epitopes peptidiques communs a des antigenes d'une meme famille multigenique | |
| WO2008005880A3 (en) | Antibodies for norovirus | |
| JP2024508683A5 (enExample) | ||
| WO2007149518A3 (en) | Dna composition against tumor stromal antigen fap and methods of use thereof | |
| WO2008020335A8 (en) | Immunogenic compositions for streptococcus agalactiae | |
| HRP20130022T1 (hr) | Fuzijski proteini koji sadrže antigene ny-eso-1 i lage-1 za odbacivanje tumora | |
| JP2014502961A5 (enExample) | ||
| JP2014504297A5 (enExample) | ||
| JP2011522777A5 (enExample) | ||
| CA2554195A1 (en) | Peptide originating in epidermal growth factor receptor (egfr) | |
| JP2006503088A5 (enExample) | ||
| TW200505943A (en) | Polypeptide | |
| ATE435660T1 (de) | Immunogenes polypeptid bestehend aus optimierten kryptischen peptiden aus tumorantigenen und seine verwendungen | |
| EA200870342A1 (ru) | Пептидные последовательности и композиции | |
| WO2002094313A3 (en) | Vaccine composition |